Cited by 142RNA Research and SplicingGenomics and Chromatin DynamicsCancer-related Molecular Pathways

Structural Analysis of the Human BIN1 Gene

Open access
Wechsler-Reya, Robert, Sakamuro, Daitoku, Zhang, Jing, Duhadaway, James, Prendergast, George C.·1997·Journal of Biological Chemistry

Abstract

BIN1 is a putative tumor suppressor that was identified through its interaction with the MYC oncoprotein. To begin to identify elements of BIN1 whose alteration may contribute to malignancy, we cloned and characterized the human BIN1 gene and promoter. Nineteen exons were identified in a region of >54 kilobases, six of which were alternately spliced in a cell type-specific manner. One alternately spliced exon encodes part of the MYC-binding domain, suggesting that splicing controls the MYC-binding capacity of BIN1 polypeptides. Four other alternately spliced exons encode amphiphysin-related sequences that were included in brain-specific BIN1 species, also termed amphiphysin isoforms or amphiphysin II. The 5'-flanking region of BIN1 is GC-rich and lacks a TATA box but directs transcriptional initiation from a single site. A approximately 0. 9-kilobase fragment from this region was sufficient for basal transcription and transactivation by MyoD, which may account for the high levels of BIN1 observed in skeletal muscle. This study lays the foundation for genetic and epigenetic investigations into the role of BIN1 in normal and neoplastic cell regulation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.272.50.31453

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • BIN1 undergoes complex alternative splicing to generate multiple isoforms with diverse functions in multiple cellular processes including endocytosis and membrane remodeling.

    “BIN1 undergoes complex alternative splicing to generate multiple isoforms with diverse functions in multiple cellular processes including endocytosis and membrane remodeling.”

    From Predominant expression of Alzheimer’s disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts (2016) · cites this paper as [12]

    The BIN1 gene-structure section reports multiple alternatively spliced BIN1 RNA species, and the Discussion suggests that some splice forms may differ in MYC interaction or amphiphysin-like functions (page unavailable). Our copy does not establish that the isoforms function in endocytosis or membrane remodeling, so those specific processes are not supported by this source. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Wechsler-Reya, R., Elliott, K., and Prendergast, G. C. (1998) Mol. Cell. Biol., in press

Cited by

Sorted by citations

Authors
Wechsler-Reya, R., Sakamuro, D., Zhang, J., Duhadaway, J., & Prendergast, G. C.
Affiliations
The Wistar Institute (US)
Corresponding author
Prendergast, George C.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
1997-12
Volume
272
Issue
50
Pages
31453-31458
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2029383449
Cited by
142
References
1
Citations by year
2026: 4 · 2025: 7 · 2024: 2 · 2023: 5 · 2022: 3 · 2021: 7 · 2020: 6 · 2019: 5 · 2018: 2 · 2016: 8 · 2015: 5 · 2014: 6 · 2013: 5 · 2012: 5
FWCI
2.02
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • American Cancer Society
  • Medical Research Council Canada
  • Medical Research Council
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords
tumor suppressor, Myc oncoprotein, alternative splicing, exon structure, promoter, GC-rich promoter, TATA box, transcription initiation, skeletal muscle, gene structure
MeSH terms
Animals, Base Sequence, Carrier Proteins, Cell Line, Chromosome Mapping, DNA, Exons, Gene Expression Regulation, Humans, Introns, Molecular Sequence Data, Nerve Tissue Proteins, Nuclear Proteins, Promoter Regions, Genetic, RNA, RNA Caps, Transcription, Genetic, Genes, Tumor Suppressor, Alternative Splicing, MyoD Protein, Tumor Suppressor Proteins, Adaptor Proteins, Signal Transducing, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review